Indian vaccine maker Bharat Biotech said to consider $500 million IPO: Report

Bharat Biotech International Ltd may launch an IPO to raise over 500 million dollars. The Hyderabad firm has delivered 9 billion vaccine doses and its portfolio includes Covid-19 and hepatitis B.

Leave a Reply

Your email address will not be published. Required fields are marked *